Scribe Therapeutics Inc. SCTX
16.30 USD -0.06 (-0.37%)
As ofNov 16, 2026, 9:42 AM EST
16.30 Day range 16.65
13.50 52-week range 39.60
- YTD
- -14.07%
- 1 year
- -14.07%
News
benzinga.com Scribe Therapeutics Q3 EPS $(0.68) Beats $(2.06) Estimate, Sales $1.600M Miss $3.113M Estimate Scribe Therapeutics (NASDAQ:SCTX) reported quarterly losses of $(0.68) per share which beat the analyst consensus estimate of $(2.06) by 66.99 percent. The company reported quarterly sales of $1.600…
globenewswire.com Scribe Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights Listed on the Nasdaq Global Market under the ticker symbol “SCTX,” and raised capital to fund the initial clinical development of STX-1150, STX-1200, and STX-1400 Continued enrollment in…benzinga.com Scribe Therapeutics To Present Data In American Heart Association’s Scientific Sessions On Its Three Clinical Programs Scribe Therapeutics Inc. ("Scribe Therapeutics" or "the Company") (Nasdaq: SCTX), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend…
